G&S Capital’s Eli Lilly LLY Stock Holding History

G&S Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$597K	Buy	498 +5	+1%	+$5.11K	0.17%	116
2026 Q1	$453K	Sell	493 -8	-2%	-$8.11K	0.16%	104
2025 Q4	$538K	Buy	501 +10	+2%	+$9.56K	0.19%	102
2025 Q3	$375K	Buy	491 +24	+5%	+$17.9K	0.14%	110
2025 Q2	$364K	Buy	467 +6	+1%	+$4.66K	0.14%	112
2025 Q1	$381K	Buy	+461	New	+$384K	0.16%	110
2023 Q1	–	Sell	-5,398	Closed	-$1.97M	–	118
2022 Q4	$1.97M	Buy	5,398 +42	+0.8%	+$14.9K	0.87%	33
2022 Q3	$1.73M	Sell	5,356 -6,478	-55%	-$2.05M	0.92%	31
2022 Q2	$3.84M	Buy	11,834 +161	+1%	+$48.3K	2.26%	13
2022 Q1	$3.34M	Buy	11,673 +229	+2%	+$58.9K	1.79%	15
2021 Q4	$3.16M	Sell	11,444 -203	-2%	-$51.5K	1.58%	16
2021 Q3	$2.69M	Buy	+11,647	New	+$2.87M	1.48%	23

Other funds holding LLY

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

G&S Capital's LLY Position: Q2 2026 in Review

G&S Capital increased its Eli Lilly (LLY) stake by 1% in Q2 2026, buying an estimated $5.11K and bringing the position to 498 shares worth $597K. The position accounts for 0.17% of the portfolio, ranked #116.

G&S Capital first reported a position in LLY in Q3 2021 and has held it in 12 quarters since. The position peaked at $3.84M in Q2 2022. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

G&S Capital held 498 shares of Eli Lilly worth $597K as of Q2 2026.
G&S Capital bought 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
Eli Lilly made up 0.17% of G&S Capital's portfolio in Q2 2026, its #116 holding.
G&S Capital first reported a position in Eli Lilly in Q3 2021 and has held it in 12 quarters since.
G&S Capital's Eli Lilly position peaked at $3.84M in Q2 2022.
841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on G&S Capital's 13F filing for Q2 2026, filed 10 Jul 2026.